References
1. Cohen EG, Shaha AR, Rinaldo A, Devaney KO, Ferlito A. 2004. Medullary thyroid carcinoma. Acta Oto-Laryngologica 124 (5):544-557.
2. Blankenship DR, Chin E, Terris DJ. 2005. Contemporary management of thyroid cancer. American Journal of Otolaryngology 26 (4):249-260.
3. Wells SA, Jr., Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG. 2015. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid : official journal of the American Thyroid Association 25 (6):567-610.
4. Pacini F, Castagna MG, Cipri C, Schlumberger M. 2010. Medullary thyroid carcinoma. Clinical oncology (Royal College of Radiologists (Great Britain)) 22 (6):475-485.
5. Moley JF. 2010. Medullary thyroid carcinoma: management of lymph node metastases. Journal of the National Comprehensive Cancer Network : JNCCN 8 (5):549-556.
6. Smit J. 2013. Treatment of advanced medullary thyroid cancer. Thyroid Res 6 Suppl 1 (Suppl 1):S7-S7.
7. Schlumberger M, Bastholt L, Dralle H, Jarzab B, Pacini F, Smit JWA. 2012. 2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer. European Thyroid Journal 1 (1):5-14.
8. van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM. 1990. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Annals of surgery 212 (4):395-400; discussion 400-391.
9. Jimenez JM, Casey SO, Citron M, Khan A. 1995. Calcified pulmonary metastases from medullary carcinoma of the thyroid. Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society 19 (4):325-328.
10. Afshar K, Alalawi R, Boylen CT. 2007. Micronodular radiographic pulmonary pattern in metastatic medullary thyroid carcinoma. Journal of the National Medical Association 99 (5):575-577.
11. Russ G. 2016. Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 35 (1):25-38.
12. Salahuddin M, Cherian S, Patel RAJ, Estrada-Y-Martin R. 2018. Etiology of miliary nodules. CHEST 154 (4):583A.
13. Khan D, Danjuma M, Saddique MU, Murshed KAH, Yassin MA. 2020. Adenocarcinoma of the Lung Mimicking Miliary Tuberculosis. Case Reports in Oncology 13 (1):139-144.
14. Manko AG, Shilo K, McCallister JW A Case Of Diffuse Miliary Pulmonary Infiltrates In A 35 Year-Old Man. American Thoracic Society. https://www.thoracic.org/professionals/clinical-resources/clinical-cases/08-14.php. Accessed June 12, 2020
15. Kimmig L, Bueno J. 2017. Miliary Nodules: Not Always Tuberculosis. Annals of the American Thoracic Society 14 (12):1858-1860.
16. Abe K, Adachi I, Miyakawa S, Tanaka M, Yamaguchi K, Tanaka N, Kameya T, Shimosato Y. 1977. Production of calcitonin, adrenocorticotropic hormone, and beta-melanocyte-stimulating hormone in tumors derived from amine precursor uptake and decarboxylation cells. Cancer research 37 (11):4190-4194.
17. Trimboli P, Treglia G, Guidobaldi L, Romanelli F, Nigri G, Valabrega S, Sadeghi R, Crescenzi A, Faquin WC, Bongiovanni M, Giovanella L. 2015. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clinical endocrinology 82 (2):280-285.
18. Papaparaskeva K, Nagel H, Droese M. 2000. Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagnostic cytopathology 22 (6):351-358.
19. Bugalho MJ, Santos JR, Sobrinho L. 2005. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. Journal of surgical oncology 91 (1):56-60.
20. Trimboli P, Cremonini N, Ceriani L, Saggiorato E, Guidobaldi L, Romanelli F, Ventura C, Laurenti O, Messuti I, Solaroli E, Madaio R, Bongiovanni M, Orlandi F, Crescenzi A, Valabrega S, Giovanella L. 2014. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clinical endocrinology 80 (1):135-140.
21. Bhanot P, Yang J, Schnadig VJ, Logroño R. 2007. Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature. Diagnostic cytopathology 35 (5):285-292.
22. Wells SA, Haagensen DE, Linehan WM, Farrell RE, Dilley WG. 1978. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma. Cancer 42 (3 Suppl):1498-1503.
23. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. 2000. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88 (5):1139-1148.
24. Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, Schlumberger M, Bigorgne JC, Dumontier P, Leclerc L, Corcuff B, Guilhem I. 1998. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d’étude des tumeurs à calcitonine. Clinical endocrinology 48 (3):265-273.